AlloMek Therapeutics, LLC — Form D/A
AlloMek Therapeutics, LLC of Woodbridge, CT, a company, filed a Form D amendment with the SEC on 2020-02-10. The offering totals $1.3M, of which $1.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-02-10
- Form: D/A
- Accession: 0001513131-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.3M
- Amount sold: $1.3M
- Investors: 1
- Date of first sale: 2016-12-21
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-280063
Issuer
- Name: AlloMek Therapeutics, LLC
- CIK: 0001513131
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: c/oCheminpharma LLC, Woodbridge, CT, 06032
- Phone: 8606796893
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Jason Fisherman | Director | Woodbridge, CT |
| Uday Khire | Director | Woodbridge, CT |
| Daniel Wagner | Director | Branford, CT |
| Uday Khire | Executive Officer | Woodbridge, CT |
| n/a Cheminpharma LLC | Promoter | Farmington, CT |
Other filings by this issuer (3)
More